This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...

Investing.com -- Barclays downgraded DexCom and Insulet, two large-cap diabetes device makers, to Underweight as it expects rising competition in 2026 and 2027 to weigh on valuation multiples and ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...

TwoMomsBuyTestStrips.com, a marketplace connecting individuals with extra diabetic supplies to those who need affordable health care solutions, is celebrating a decade of service with a ...

Bringing its total Series D funds to $98m, ViCentra plans to boost manufacturing capabilities for its Kaleido insulin pump and prepare for a US market entry.

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.

Diabeloop receives US FDA 510(k) clearance for DBLG2, an automated insulin delivery algorithm: Grenoble, France Saturday, January 10, 2026, 10:00 Hrs [IST] Diabeloop, a global com ...

TwoMomsBuyTestStrips.com, a trusted marketplace connecting individuals with extra diabetic supplies to those who need affordable healthcare solutions, is celebrating a decade of service with ...

Newsweek and BrandSpark International are proud to announce the winners of the 2026 Newsweek / BrandSpark Most Trusted® Awards, celebrating the brands that have earned the trust of UK shoppers. This ...

Insulin patch pump maker ViCentra announced today that it closed a $13 million extension to its Series D financing round.

The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal ...